Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Sickle cell trait and diabetes tests: What every healthcare provider should know
source: Centers for Disease Control and Prevention
year: N/A
summary/abstract:According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the hemoglobin A1C assay may be unreliable for diagnosing and monitoring diabetes and prediabetes in individuals with sickle cell trait (SCT) or other hemoglobinopathies. In order to provide the best possible care for your patients, it is important to determine their SCT status and know whether the A1C test you normally use should be replaced or supplemented with a different test.
Can the hemoglobin A1C test identify SCT?
No. The hemoglobin A1C test is not designed to look for SCT, but some test methods for hemoglobin A1C might detect“variant hemoglobin,” which could in some cases be sickle hemoglobin. However, this result should not be considered a diagnostic test for SCT. SCT should be diagnosed only by using a test approved for hemoglobin identification.
read more
+myBinderRelated Content
-
Sickle cell traitThe NCAA Sport Science Institute is comm...
-
Williams excels on soccer field while playing with sickle cell traitWomen’s soccer sophomore midfielder Al...
-
Anemia falciforme (sickle cell disease) y portadores del gen de anemia falciformeLa anemia falciforme es un trastorno her...
-
Black Americans With Sickle Cell Trait At Increased Risk Of Kidney DiseaseAfrican Americans with sickle cell trait...
-
Indiana Sickle Cell Conference 2020 – VirtualThis one-day conference will provide hel...
-
Malaria-Driven Sickle Cell Trait Selection – Evidence for Modern Day Human Evolution?Sickle cell disease poses a serious heal...
-
Study challenges view that sickle cell trait increases mortality riskSurprising findings from a study of heal...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.